SUBHKAM VENTURES
Alivus Life Sciences block deal: Promoter Nirma sells over 28 lakh shares worth Rs 390 crore; Norges Bank, Helios MF among buyers
Nirma sold 28.46 lakh Alivus Life Sciences shares worth Rs 390 crore through a block deal at Rs 1,370 apiece. Norges Bank, Bandhan MF and others bought shares as Alivus reported strong Q2FY27 earnings growth.
The anatomy of corporate control
In a major change to India’s corporate governance, the regulatory framework is set to redefine "control" with reference to the business and investment regime. The previous construct of foreign owned and controlled companies is being phased out in favour of defining foreign controlled entities. The approach is set to shift from a one-size-fits-all test to a more context-sensitive evaluation.
Fusion Klassroom raises over Rs 11 crore from anchor investors; SME IPO to open on Friday
Fusion Klassroom Edutech has successfully secured Rs 11.08 crore from key anchor investors. The company is set to launch its initial public offering on July 31st, with the IPO valued at Rs 39.04 crore, which will remain open until August 4th. Following the offering, shares are expected to be listed on the BSE SME platform on August 7th.
KRN Heat Exchanger and Refrigeration raises Rs 350 crore via QIP
KRN Heat Exchanger and Refrigeration Ltd successfully raised Rs 350 crore via a qualified institutional placement, attracting significant investment from entities like the Abu Dhabi Investment Authority and WhiteOak Capital.
Jaro Institute IPO: Edtech company raises Rs 135 crore from anchor investors ahead of Tuesday launch
Jaro Institute of Technology Management & Research raised ₹135 crore from 19 anchor investors ahead of its ₹450 crore IPO. Strong demand from marquee funds lifted its GMP to ₹111, signaling a potential 12.5% listing gain.
Ashish Kacholia invests in Ganesh Consumer's Rs 122 crore anchor round ahead of IPO
Ganesh Consumer Products raised Rs 122 crore from anchor investors ahead of its Rs 409 crore IPO opening on September 22. Marquee domestic and global funds subscribed shares at Rs 322 per share.
- Go To Page 1
Ahead of IPO, Ganesh Consumer Products raises Rs 122 cr from anchor investors
Ganesh Consumer Products Ltd, a key player in packaged food products in eastern India, on Friday said it has raised over Rs 122 crore from anchor investors, ahead of its initial share-sale opening for public subscription.
PB Fintech founders sell over 1% stake for Rs 920 crore
PB Fintech's co-founders, Yashish Dahiya and Alok Bansal, sold a little over 1% stake in the company for ₹920 crore through open market transactions. Dahiya and Bansal offloaded 50.50 lakh shares, reducing their holdings. The shares were acquired by domestic mutual funds, insurance companies, and foreign investors, including Tata Mutual Fund and Goldman Sachs.
Startups & the new data law; Sachin Bansal’s Ola stake
Happy Tuesday! The draft Digital Personal Data Protection Act, 2023, has created new opportunities for startups in the tech sector. This and more in today’s ETtech Morning Dispatch.
Subhkam Ventures leads $6.2 million round in battery-tech startup Emo Energy
New and existing investors Microtek Group, SRK Family Office, and Transition VC also participated. It last raised $1.2 million in May 2024 in a funding round led by Transition VC and Gruhas. The funds will be used to scale its two- and three-wheeler energy solution to over one lakh vehicles over the next two years, invest in R&D capabilities for its proprietary battery health extension software and expand the team.
Transrail Lighting raises Rs 245.97 crore from anchor investors ahead of IPO
Winro Commercial (India) secured the top allocation at 19.51%, followed by ICICI Prudential Energy Opportunities Fund and Tata ELSS Tax Saver Fund with 9.35% each, and Bengal Finance and Investments at 8.13%, as per the exchange filing.
Mamata Machinery secures Rs 53 cr from anchor investors
Packaging machinery manufacturer Mamata Machinery Ltd on Wednesday said it has raised over Rs 53 crore from anchor investors ahead of its initial public offering (IPO).
Interarch Building Products IPO: Company raises Rs 179 crore from anchor investors ahead of issue
The company announced to the stock exchanges that it has allocated 1,994,288 shares to anchor investors at Rs 900 per share on Friday. Out of these, 716,592 shares, valued at approximately Rs. 64.49 crore, were allocated to 3 domestic mutual funds across 8 schemes. This represents 35.93% of the total anchor investor allocation.
Wockhardt shares hit 5% upper circuit after Prashant Jain, Madhusudan Kela and others invest in QIP
3P India Equity Fund, managed by Prashant Jain, and Madhusudan Kela's Cohesion MK Best Ideas sub-trust are among those funds that have received 5% or more shares in the Qualified Institutional Placement (QIP) of shares.
GPT Healthcare garners Rs 157 cr from anchor investors ahead of IPO
GPT Healthcare Ltd, which operates and manages mid-sized multi-specialty hospitals under the ILS Hospitals brand, on Wednesday collected Rs 157.54 crore from anchor investors a day before its Initial Public Offering (IPO).
Credo Brands raises Rs 165 crore from anchor investors; RBZ Jewellers bags Rs 25 crore
In case of Credo Brands, out of the total allocation of 58.9 lakh equity shares to anchor investors, 24.99 lakh shares were allocated to domestic mutual funds through a total of 3 schemes amounting to Rs 70 crore which is 42.4% of the total anchor book size.
Frustrated investors left empty-handed in IndiGo block trade
None of the investors lined up by the banks working on billionaire Rakesh Gangwal’s sale of part of his family’s stake in IndiGo got any shares in the block trade as a result of slippage, a phenomenon where orders aren’t filled due to the presence of bids with a higher competing price, according to people with knowledge of the matter.
How Krishna Ella built Bharat Biotech and why the company is at a tipping point
Bharat Biotech’s Covaxin is India’s first indigenous coronavirus vaccine. The DCGI’s approval of Covaxin, despite it not having phase-3 clinical trial efficacy and safety data, stunned several vaccine experts. Many expressed doubts about the company’s clinical trial processes. A moment of triumph became a defensive one for Bharat Biotech’s founder-CMD M Krishna Ella.
AI analytics startup Synctag raises series-A funds
This is the fourth round of funding for Synctag, which manages social, email, content and other media for clients.
Investor rush picks up for IRB InvITs post-IPO
Driven by higher demand, the price rose as much as Rs 105 pulling down yield by 50 basis pts.
Carlyle Group emerges front-runner for Bharat Biotech stake
The firm counts domestic private equity fund ICICI Ventures, International Finance Corp, the global investment arm of the World Bank and Subhkam Ventures as its investors.
Bharat Biotech likely to be valued at $600 million as top PE firms queue up to buy stake
Domestic private equity fund ICICI Venture, International Finance Corp, the investment arm of World Bank, will exit their almost 10-yr investment in Bharat Biotech.
Global private equity giants eye stake in Bharat Biotech
Hyderabad based biotechnology firm Bharat Biotech which recently claimed that it was probably the first company in the world to file global patents for Zika vaccines.
'Control' may remain a sticky issue in M&As
The definition of 'control', which lies at the heart of every M&A deal, continues to remain unchanged despite the word being a subject of multiple litigations.
Post-slump, commodity firms shine on PE radar
PE firms focus on agri and food companies.
Speculation over Welspun Gujarat-MSK Projects buy
Talk of Welspun Gujarat Stahl Rohren looking to buy MSK Projects refuses to die despite the latter denying it.
Heard on the street
TALK of Welspun Gujarat Stahl Rohren looking to buy MSK Projects refuses to die despite the latter denying it
Subhkam Ventures ups its stake in Shakti Pumps
Private equity firm, Subhkam Ventures, on Thursday said it has increased its stake in steel submersible pump manufacturer, Shakti Pumps, from three per cent to 12.05 per cent.
Load More
